SEARCH HEALTH CONDITIONS BY ALPHABETS
Paroxysmal Nocturnal Hemoglobinuria
Medications for Paroxysmal Nocturnal Hemoglobinuria
Around Paroxysmal Nocturnal Hemoglobinuria: Paroxysmal nocturnal hemoglobinuria is a rare, blood cell abnormality in which red blood cells break down early in the day than normal. Hemoglobin is leaked by the cells into the bloodstream, and this can pass in the urine.
Drugs Used to Heal Paroxysmal Nocturnal Hemoglobinuria
The following list of medications are in some way related to, or used at the treatment of this particular condition.
| Medication title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Soliris | Rx | C | N | Add inspection | 0.0 | ||
Generic name: eculizumab systemic Medication class: discerning immunosuppressants For customers: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| eculizumab | Rx | C | N | Add inspection | 0.0 | ||
Generic name: eculizumab systemic Brand name: Soliris Medication class: discerning immunosuppressants For customers: dosage, interactions, For specialists: a Z Drug Truth, AHFS DI Monograph | |||||||
| ravulizumab | Rx | N | Add inspection | 0.0 | |||
Generic name: ravulizumab systemic Brand name: Ultomiris Medication class: discerning immunosuppressants For customers: dosage, For specialists: a Z Drug Truth, AHFS DI Monograph | |||||||
| Ultomiris | Rx | N | Add inspection | 0.0 | |||
Generic name: ravulizumab systemic Medication class: discerning immunosuppressants For customers: dosage, side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over the Counter |
| Away Prizes | This drug might not be approved by the FDA for treating this particular condition. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to demonstrate a risk to the embryo within the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have shown a negative effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in used in pregnant women clearly outweigh potential benefits. |
| N | FDA has not classified the medication. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | isn`t subject to the Controlled Substances Act. |
| 1 | Has a high potential for abuse. Has no accepted medical use in treatment in the United States. There`s a lack of accepted safety for use under medical supervision. |
| Two | Has a high potential for abuse. Includes a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Abuse may cause severe physical or psychological dependency. |
| 3 | features a potential for abuse less than individuals in schedules 1 and 2 2. Includes a currently accepted medical use in treatment in the United States. Abuse may lead to physical dependence or high psychological dependence. |
| 4 | Has a low potential for abuse relative to individuals in program 3. It`s a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in program 3. |
| 5 | Has a low potential for abuse relative to individuals in program 4. Includes a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Dtc
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always ask your physician to make sure the information relates to some circumstances.
- Painful Coitus (Female)
- Painful Intercourse
- Pancreatic Exocrine Dysfunction
- Pancreatic Secretion
- Pancreatogenic Diabetes
- PANDAS Syndrome
- Panhypopituitarism
- Panuveitis
- Papilledema Associated with Increased Intracranial Pressure
- Papilledema Associated with Retinal Disorder
- Paracoccidioidomycosis
- Paradoxical Vocal Cord Dysfunction (PVCD)
- Paradoxical Vocal Cord Motion Disorder (PVCM)
- Paragonimus Westermani, Lung Fluke
- Paralytic Disorder
- Paraphimosis
- Paraplegia
- Parathyroid Cancer
- Parotid Tumors
- Paroxysmal Atrial Tachycardia
- Paroxysmal Junctional Tachycardia
- Paroxysmal Nocturnal Hemoglobinuria
- Paroxysmal Supraventricular Tachycardia
- Parsonage Turner Syndrome
- Patency Maintenance of Indwelling Intravenous Devices
- Pathological Hypersecretory Conditions
Top USA Pharma Companies
Popular Categories
Health Condition
- Painful Coitus (Female)
- Painful Intercourse
- Pancreatic Exocrine Dysfunction
- Pancreatic Secretion
- Pancreatogenic Diabetes
- PANDAS Syndrome
- Panhypopituitarism
- Panuveitis
- Papilledema Associated with Increased Intracranial Pressure
- Papilledema Associated with Retinal Disorder
- Paracoccidioidomycosis
- Paradoxical Vocal Cord Dysfunction (PVCD)
- Paradoxical Vocal Cord Motion Disorder (PVCM)
- Paragonimus Westermani, Lung Fluke
- Paralytic Disorder
- Paraphimosis
- Paraplegia
- Parathyroid Cancer
- Parotid Tumors
- Paroxysmal Atrial Tachycardia
- Paroxysmal Junctional Tachycardia
- Paroxysmal Nocturnal Hemoglobinuria
- Paroxysmal Supraventricular Tachycardia
- Parsonage Turner Syndrome
- Patency Maintenance of Indwelling Intravenous Devices
- Pathological Hypersecretory Conditions
Easily find an affordable health insurance plan
